Archive · 26 Aug 2026
SynbioTech to Showcase TWK10® in GLP-1 Nutrition Market
SynbioTech makes products that use probiotics and other microbiome technologies.
It will show one product, called TWK10®, at a nutrition trade show in Bangkok.
The company says new weight-management medicines are making brands think about more than just eating less.
They are also considering protein, muscles, movement and healthy aging.
Two studies described by the company tested TWK10® in different groups of people.
One study combined it with pea protein and exercise.
Another studied frail older adults for 18 weeks.
The studies reported improvements in some measures of amino acids, strength and movement.
These results are research findings, and SynbioTech is presenting them to companies developing nutrition products.
SynbioTech will present TWK10® and its microbiome CDMO platform at Vitafoods Asia 2026 in Bangkok from September 2–4.
The company is positioning TWK10® for companion nutrition products focused on protein utilization, muscle support, gut health and healthy aging.
A 28-day study combining pea protein and resistance training reported increases in amino-acid measures and improvements in several physical-performance outcomes.
An 18-week trial in frail older adults reported gains in grip strength, relative muscle mass, chair-stand performance and walking-balance measures.
SynbioTech says TWK10® has 27 scientific publications, nine human clinical studies, 18 global patents and regulatory milestones in several markets.
- Who
- SynbioTech, a Taiwan-based biotechnology company, and brands developing nutrition products.
- What
- SynbioTech will present Lactiplantibacillus plantarum TWK10® and its microbiome-focused contract development and manufacturing organization platform.
- When
- September 2–4, 2026.
- Where
- Vitafoods Asia 2026 at the Queen Sirikit National Convention Center in Bangkok, Thailand; SynbioTech will exhibit at Booth H7-N32B.
- Why
- The company aims to address growing interest in nutrition products accompanying GLP-1-based weight-management therapies, particularly products related to protein utilization, muscle support and healthy aging.
- Company
- SynbioTech, founded in Taiwan in 2000, specializes in probiotics, postbiotics and microbiome-based health solutions.
- Featured ingredient
- Lactiplantibacillus plantarum TWK10®.
- Research record
- 27 scientific publications and nine human clinical studies, according to SynbioTech.
- Clinical finding
- In an 18-week trial involving frail older adults, the high-dose group recorded a 51% improvement in 30-second Chair Stand performance from baseline.
- Regulatory milestones
- SynbioTech cites a Taiwan anti-fatigue health claim, self-affirmed GRAS status in the United States, recognition in Korea, acceptance under Japan’s Foods with Function Claims system and Malaysia registration.
- Thailand status
- TWK10® was added to Thailand’s approved edible microbial strain list in 2024.
- CDMO services
- The platform covers strain selection, formulation development, clinical-study design, manufacturing and regulatory-documentation support.